Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4057)	2/9/1998 11:37:00 PM
From: Rocketman	Respond to of 9719

Top Ten Unusual Comments on Monica Lewinsky's Intern Performance Report 10. Truly an eager beaver. 9. Uses too much teeth. 8. Stays late, comes early. 7. Excellent oral dictation skills: has never missed a period. 6. Great attitude! Willing to accept a heavy load. 5. Frequently complains of jaw pain. 4. Although not a whiner, tends to be a moaner. 3. "In box" is always clean and shiny. 2. Tends to blab on the telephone. 1. This intern may suck, but she doesn't inhale PB, Hope this fills your request. Rman

To: Pseudo Biologist who wrote (4057)	2/11/1998 2:40:00 AM
From: Vector1	Respond to of 9719

<<What's the view on the PCOP+MSI merger deal? >> I think it is a great deal for PCOP. The combination of the leader in combinatorial chemistry and computer drug modeling software is very powerful. MSI is the dominant player in the field Trpos notwithstanding. This company could rival INCY in power one day if they execute. In fact they are one step higher in the drug development food chain. What do you think. I think we should add PCOP to the Model as soon as we clear margin. SEPR is also very high on my list. V1